CAR T Cell Therapy Targeting G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D), a Novel Target for the Immunotherapy of Multiple Myeloma

Eric L. Smith, Kimberly Harrington , Mette Stæhr, Reed Masakayan, Jon Jones, Thomas Long, Majid Ghoddusi, Terence J. Purdon, Trevor Do, Xiuyan Wang, Minh Pham, Jessica M Brown, Elizabeth Peguero, Carlos Fernandez De Larrea, Pei Wang, Hong Liu, Yiyang Xu, Sarah Garrett, Steven Almo, Isabelle RiviereCheng Liu, Blythe Duke Sather, Renier J. Brentjens

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind132
Udgave nummerSuppl. 1
Sider (fra-til)589
ISSN0006-4971
DOI
StatusUdgivet - 29. nov. 2018
Udgivet eksterntJa
Begivenhed60th ASH Annual Meeting - San Diego, USA
Varighed: 1. dec. 20184. dec. 2018

Konference

Konference60th ASH Annual Meeting
LandUSA
BySan Diego
Periode01/12/201804/12/2018

Citationsformater

Smith, E. L., Harrington , K., Stæhr, M., Masakayan, R., Jones, J., Long, T., Ghoddusi, M., Purdon, T. J., Do, T., Wang, X., Pham, M., Brown, J. M., Peguero, E., De Larrea, C. F., Wang, P., Liu, H., Xu, Y., Garrett, S., Almo, S., ... Brentjens, R. J. (2018). CAR T Cell Therapy Targeting G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D), a Novel Target for the Immunotherapy of Multiple Myeloma. Blood, 132(Suppl. 1), 589. https://doi.org/10.1182/blood-2018-99-110471